PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS

✍ Scribed by Erder, M.; Chen, K.; Wu, E.Q.; Hodgkins, P.; Sikirica, V.

• Book ID: 122879638
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 57 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.02.1061